Doctors Note Logo

Published on: 8/18/2026

Vitamin D Resistant Rickets: Next Steps

Vitamin D resistant rickets, most often X-linked hypophosphatemia, usually does not improve with standard vitamin D supplements because the root problem is phosphate loss through the kidneys rather than a simple deficiency. Next steps generally involve blood and urine testing for phosphate, alkaline phosphatase, calcium, PTH and FGF23, leg and wrist X-rays, genetic testing, and referral to an endocrinologist, nephrologist or metabolic bone specialist, with treatment options that may include oral phosphate plus active vitamin D (calcitriol) or targeted therapy such as burosumab. Ongoing dental care, orthopedic monitoring for bowed legs, growth tracking and periodic kidney and calcium checks are also part of long term management. Because the right plan depends on age, genetic cause, severity and prior treatment response, there are several important factors to consider before deciding what to do next, so see below to understand more.

Bone pain, delayed growth, dental abscesses and leg deformity can point to several different conditions, and sorting through them alone is difficult. A free, instant, online <a href="https://ubiehealth.com

answer background

Explanation

Vitamin D Resistant Rickets: Next Steps

Vitamin D resistant rickets is a rare disorder in which the body cannot use vitamin D effectively to build and strengthen bones. Unlike classic rickets caused by vitamin D deficiency, this form often stems from genetic changes affecting phosphate handling in the kidneys and bone mineralization. Early recognition and the right next steps can help manage symptoms, improve bone health, and support growth.

Understanding Vitamin D Resistant Rickets

Vitamin D resistant rickets is most often linked to disorders of phosphate regulation. Key features include:

  • Impaired phosphate reabsorption in the kidneys
  • Low blood phosphate levels (hypophosphatemia)
  • Normal to low active vitamin D levels despite supplementation

Common types:

  • X-linked hypophosphatemia (XLH): The most frequent form, caused by mutations in the PHEX gene.
  • Autosomal dominant hypophosphatemic rickets (ADHR): Linked to FGF23 gene mutations.
  • Autosomal recessive hypophosphatemic rickets (ARHR): Less common, involving other genes (e.g., DMP1).

Each type disrupts the balance of phosphate and vitamin D needed for healthy bone formation.

Typical Signs and Symptoms

Symptoms often appear in early childhood but may vary in severity:

  • Delayed growth and short stature
  • Bowed or curved legs, knock-knees
  • Bone pain or tenderness in legs, ribs, spine
  • Frequent fractures or stress fractures
  • Dental problems, such as abscesses or weak enamel
  • Muscle weakness or fatigue

Because symptoms overlap with other bone disorders, careful evaluation is needed.

Confirming the Diagnosis

A thorough assessment includes:

Laboratory Tests

  • Serum phosphate: consistently low
  • Alkaline phosphatase (ALP): elevated, reflecting increased bone turnover
  • 25-hydroxyvitamin D: normal or low
  • 1,25-dihydroxyvitamin D (calcitriol): inappropriately normal or low
  • Parathyroid hormone (PTH): normal to mildly elevated
  • FGF23 levels (when available): often high

Imaging

  • X-rays of long bones: characteristic “cupping” and widening of growth plates
  • Bone density scan (DXA): to assess mineral density

Genetic Testing

  • Identifies the specific mutation (PHEX, FGF23, DMP1, etc.)
  • Helps guide prognosis and family counseling

Genetic Counseling and Family Screening

Because vitamin D resistant rickets often runs in families:

  • Discuss genetic counseling to understand inheritance patterns
  • Offer testing to siblings or relatives at risk
  • Provide education about future pregnancy decisions

Early detection in family members can prompt monitoring before symptoms worsen.

Working with a Specialist Team

Managing vitamin D resistant rickets usually involves a multidisciplinary team:

  • Pediatric endocrinologist or metabolic bone specialist
  • Nephrologist (kidney expert)
  • Orthopedic surgeon (for bone deformities or fractures)
  • Dentist or oral surgeon (for dental complications)
  • Physical therapist (to improve strength and mobility)

Regular communication between specialists ensures coordinated care and adjusts treatment as your child grows.

Medical Treatment Options

The primary goals are to normalize phosphate levels, support bone mineralization, and relieve pain. Common approaches:

  • Phosphate supplements (oral): Multiple daily doses to raise serum phosphate
  • Active vitamin D analogs (calcitriol or alfacalcidol): Bypass renal activation to boost calcium and phosphate absorption
  • Burosumab (for XLH): A monoclonal antibody that targets excess FGF23, improving phosphate retention and bone health
  • Pain management: Acetaminophen or non-steroidal anti-inflammatories (NSAIDs), under medical supervision

When to consider specialist treatments:

  • Persistent symptoms despite standard therapy
  • Severe bone deformities affecting mobility
  • Inadequate growth response

Monitoring and Adjusting Therapy

Regular follow-up is essential to balance benefits and potential side effects:

  • Serum phosphate, calcium, PTH, and ALP every 3–6 months
  • Kidney ultrasound annually to screen for nephrocalcinosis (calcium deposits)
  • Growth measurements and developmental assessments
  • Dental exams every 6–12 months

Your care team will adjust supplement doses, vitamin D analogs, or burosumab based on lab results and symptoms.

Lifestyle and Nutritional Support

While medical therapy is key, these steps help optimize bone health:

  • Balanced diet rich in calcium and phosphate
    • Dairy products (milk, yogurt, cheese)
    • Lean meats, poultry, fish
    • Nuts, seeds, beans
  • Adequate hydration to support kidney function
  • Safe, regular physical activity to strengthen bones and muscles
  • Protective measures to reduce fall risk (non-slip mats, supportive footwear)
  • Sunlight exposure as tolerated (though it won’t fully correct phosphate handling)

Work with a registered dietitian to tailor meal plans and ensure nutritional needs are met.

Managing Orthopedic and Dental Issues

Severe bone deformities or fractures may require:

  • Bracing or corrective orthopedic surgery to realign bones
  • Physical therapy for mobility and muscle strength
  • Dental interventions for abscesses, cavities, or misaligned teeth

Early referral to orthopedic and dental specialists can prevent complications and improve quality of life.

Emotional and Social Support

A chronic condition can impact daily life. Consider:

  • Patient support groups for families facing similar challenges
  • School accommodations (extra rest, modified physical education)
  • Counseling or mental health support for stress management
  • Educational materials to help teachers and peers understand the condition

Building a support network helps children and caregivers cope and thrive.

When to Seek Further Medical Advice

If you notice any of the following, contact your healthcare team promptly:

  • Severe bone pain or sudden inability to bear weight
  • Signs of high calcium in blood (nausea, confusion, extreme thirst)
  • Worsening kidney function or urinary pain
  • Rapidly declining growth or new deformities

For a free, online symptom check, using the doctor approved Ubie Symptom Checker, visit https://ubiehealth.com/.

Next Steps and Talking to Your Doctor

If you suspect vitamin D resistant rickets or have concerns about growth, bone pain, or family history:

  1. Gather records of blood tests, X-rays, and any genetic results.
  2. Schedule an appointment with a pediatric endocrinologist or metabolic bone specialist.
  3. Ask about genetic counseling and potential family screening.
  4. Discuss current and alternative treatment options, including burosumab.
  5. Develop a long-term plan for monitoring growth, kidney health, and bone density.

Always speak to a doctor about anything that could be life threatening or serious. Early intervention can prevent complications and give your child the best possible outcome.


Vitamin D resistant rickets presents unique challenges, but with a clear plan—specialist care, targeted therapies, and ongoing support—you can take meaningful next steps toward healthier bones and stronger growth.

(References)

  • * Baroncelli GI, Toschi B, Bertelloni S. Hypophosphatemic rickets. Curr Opin Endocrinol Diabetes Obes. 2012 Dec;19(6):460-7. doi: 10.1097/MED.0b013e328358be97. PMID: 23108197.

  • * Bitzan M, Goodyer PR. Hypophosphatemic Rickets. Pediatr Clin North Am. 2019 Feb;66(1):179-207. doi: 10.1016/j.pcl.2018.09.004. PMID: 30454743.

  • * Haffner D, Emma F, Eastwood DM, Biosse Duplan M, Bacchetta J, Schnabel D, Wicart P, Bockenhauer D, Santos F, Levtchenko E, Harvengt P, Kirchhoff M, Di Rocco F, Chaussain C, Brandi ML, Savendahl L, Briot K, Kamenicky P, Rejnmark L, Linglart A. Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia. Nat Rev Nephrol. 2019 Jul;15(7):435-455. doi: 10.1038/s41581-019-0152-5. PMID: 31068690; PMCID: PMC7136170.

  • * Ackah SA, Imel EA. Approach to Hypophosphatemic Rickets. J Clin Endocrinol Metab. 2022 Dec 17;108(1):209-220. doi: 10.1210/clinem/dgac488. PMID: 35981346; PMCID: PMC9759174.

  • * Miller WL, Imel EA. Rickets, Vitamin D, and Ca/P Metabolism. Horm Res Paediatr. 2022;95(6):579-592. doi: 10.1159/000527011. Epub 2022 Nov 29. PMID: 36446330.

  • * Chinoy A, Padidela R. Refractory Rickets. Indian J Pediatr. 2023 Jun;90(6):574-581. doi: 10.1007/s12098-023-04538-4. Epub 2023 Apr 19. PMID: 37074534; PMCID: PMC10212799.

  • * Kamenický P, Briot K, Munns CF, Linglart A. X-linked hypophosphataemia. Lancet. 2024 Aug 31;404(10455):887-901. doi: 10.1016/S0140-6736(24)01305-9. Epub 2024 Aug 21. PMID: 39181153.

  • * Haffner D, Emma F, Seefried L, Högler W, Javaid KM, Bockenhauer D, Bacchetta J, Eastwood D, Biosse Duplan M, Schnabel D, Wicart P, Ariceta G, Levtchenko E, Harvengt P, Kirchhoff M, Gardiner O, Di Rocco F, Chaussain C, Brandi ML, Savendahl L, Briot K, Kamenický P, Rejnmark L, Linglart A. Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia. Nat Rev Nephrol. 2025 May;21(5):330-354. doi: 10.1038/s41581-024-00926-x. Epub 2025 Jan 15. PMID: 39814982.

  • * Ali DS, Carpenter TO, Imel EA, Ward LM, Appelman-Dijkstra NM, Chaussain C, Jan de Beur SM, Florenzano P, Abu Alrob H, Aldabagh R, Alexander RT, Alsarraf F, Beck-Nielsen SS, Biosse-Duplan M, Crowley RK, Dandurand K, Filler G, Friedlander L, Fukumoto S, Gagnon C, Goodyer P, Grasemann C, Grimbly C, Hussein S, Javaid MK, Khan S, Khan A, Lehman A, Lems WF, Lewiecki EM, McDonnell C, Mirza RD, Morgante E, Morrison A, Portale AA, Rao C, Rhee Y, Rush ET, Siggelkow H, Tetradis S, Tosi L, Guyatt G, Brandi ML, Khan AA. X-Linked Hypophosphatemia Management in Children: An International Working Group Clinical Practice Guideline. J Clin Endocrinol Metab. 2025 Jun 17;110(7):2055-2070. doi: 10.1210/clinem/dgaf093. PMID: 39960858; PMCID: PMC12187519.

  • * Böckmann I, Haffner D. The Diagnosis and Therapy of XLH. Calcif Tissue Int. 2025 Apr 28;116(1):66. doi: 10.1007/s00223-025-01374-w. Epub 2025 Apr 28. PMID: 40295317; PMCID: PMC12037658.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.